Navigation Links
Cell Therapeutics, Inc.'s (CTI) Rodman & Renshaw Healthcare Conference Presentation to be Webcast

SEATTLE, Sept. 9 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) management will present at the Rodman & Renshaw 11th Annual Healthcare Conference on Wednesday, September 9th at 11:40 AM Eastern in the Spellman Salon (5th Floor) at the New York Palace Hotel.

The conference will also be webcast live with slides and available for replay after the presentation. The webcast can be accessed at

                Rodman & Renshaw 11th Annual Healthcare Conference
                     CTI Presentation: Wednesday, September 9
                        11:40 AM ET/5:40 PM CET/8:40 AM PT
              Audio webcast with slides at

    Media Contact:
    Dan Eramian
    T: 206.272.4343
    C: 206.854.1200
    F: 206.272.4434

    Investors Contact:
    Ed Bell
    T: 206.272.4345
    Lindsey Jesch Logan
    T: 206.272.4347
    F: 206.272.4434

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Oxygen Biotherapeutics, Inc. to Begin Oxycyte(R) Phase II Clinical Trials in Switzerland
2. Rx for Africa, Inc. and Zirus, Inc. Create Joint Venture, ZiRx Therapeutics, Ltd.
3. Cell Therapeutics, Inc. (CTI) to Report Second Quarter Financial Results on August 6
4. Cell Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Warrants
5. Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement
6. Cell Therapeutics, Inc. Announces Public Offering of Common Stock and Warrants
7. Oxygen Biotherapeutics, Inc. Announces Closing of Offer to Acquire Warrants
8. QuikByte Software, Inc. and Sorrento Therapeutics, Inc. Announce Merger Agreement
9. European Medicines Agency (EMEA) Approves Cell Therapeutics, Inc.s September Meeting Request to Discuss OPAXIO(TM) Marketing Authorization Application
10. Oxygen Biotherapeutics, Inc. Announces Private Placement Financing Agreement and Offer to Acquire Warrants
11. Prospect Therapeutics, Inc.s GCS-100 Exhibits a Low Toxicity Profile in Cancer Patients
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... ... development solutions for drugs, biologics, consumer health and animal health products, today announced ... will lead a new, dedicated global team of drug development and technology experts. ...
(Date:10/12/2015)... Nashville, TN (PRWEB) , ... October 13, 2015 ... ... the recipients of its biannual Heroes in Recovery Awards at Foundations Recovery Network’s ... Foundations Recovery Network presented the one-of-a-kind awards to Noah Levine and Dean Dauphinais ...
(Date:10/12/2015)... ... October 13, 2015 , ... North American Tool Corporation has been named ... National Meeting in Rosemont, IL on October 4th. , Each year, ... excellence that customers have come to expect from members of IBC’s marketing group. ...
(Date:10/12/2015)... ... ... of the “Check-In and Win a Vacation to Hawaii” Facebook contest at Gold’s Gym ... didn’t believe I could win a free vacation simply by checking in on Facebook every ... and invest in my own health – and now I’m going to Hawaii.” , Thanks ...
(Date:10/12/2015)... ... , ... Amerec , a leader in the steam and sauna industry, ... be displaying custom sauna and steam room solutions at the ISPA Conference & Expo ... customers, SpaEquip is recognized for their ability to assist in the design and implementation ...
Breaking Medicine News(10 mins):
(Date:10/12/2015)... Minn. , Oct. 12, 2015 Device ... a need to help integrate these devices into existing ... of ergonomic healthcare mounting and mobility solutions, has launched ... lightest cart yet, for a wide array of laptops ... Cart SV10 was developed exclusively for Microsoft Surface and ...
(Date:10/12/2015)... , October 12, 2015 ... Forecast to grow at 7.2% CAGR, microscopy ... by rising focus on nanotechnology, technological advancements, ... research report available with ... . --> Complete report ...
(Date:10/12/2015)... England , Oct. 12, 2015 Indivior PLC ... the District of Delaware granted the ... Teva Pharmaceuticals, Abbreviated New Drug Application (ANDA) No. 205299 to ... SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII) in ... --> Since August 2013, Indivior has received Paragraph ...
Breaking Medicine Technology: